Evidence map›Paper›PMID 35581665›Full record

ArticleJournal of medical case reports2022

Primary psoas tuberculosis abscess with an iliac bone lytic lesion: a case report.

Abdul Fattah Mohandes, Bahjat Karam, Ali Alrstom, Lugien Alasadi, Mohammad Wahid Rajab Bek, Nizar Daher, Tamim Alsuliman, Raed Abouhareb

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Abdul Fattah MohandesFaculty of Medicine, Aleppo University, Aleppo, Syria. dr.abd.mohandes@gmail.com.ORCID http://orcid.org/0000-0002-6506-0851
Bahjat KaramChildren's Hospital, Faculty of Medicine, Damascus University, Damascus, Syria.
Ali AlrstomInfectious Disease, Internal Medicine Department, Al-Mouwasat Hospital, Damascus University, Damascus, Syria.
Lugien AlasadiGastroenterology and Hepatology, Internal Medicine Department, AL-Mouwasat Hospital, Damascus University, Damascus, Syria.
Mohammad Wahid Rajab BekInfectious Disease, Internal Medicine Department, Al-Mouwasat Hospital, Damascus University, Damascus, Syria.
Nizar DaherInfectious Disease, Internal Medicine Department, Al-Mouwasat Hospital, Damascus University, Damascus, Syria.
Tamim AlsulimanService d'Hématologie, hôpital Saint-Antoine, AP-HP, Sorbonne Université, 75012, Paris, France.
Raed AbouharebGastroenterology and Hepatology, Internal Medicine Department, AL-Mouwasat Hospital, Damascus University, Damascus, Syria.
Al Assad University Hospital · SYHospital Damas · PRDamascus University · SYSorbonne Université · FRSyrian Private University · SYUniversity of Aleppo · SY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary psoas tuberculosis is the presence of "Koch's bacillus'' within the iliopsoas muscle caused by hematogenous or lymphatic seeding from a distant site. Muscular tuberculosis has relatively low prevalence in comparison with other cases of extrapulmonary tuberculosis, which explains the difficulties in establishing the diagnosis. CASE PRESENTATION: In this report, we present a challenging diagnostic case of primary psoas tuberculosis in a 38-year-old middle eastern female from southern Syria. The diagnosis was based on the clinical orientation, the observation of pulmonary lesions on the computed tomography scan, and the necrotic signs in the vicinity of the infected area. Despite the misleading primary false-negative results, the final diagnosis was reached after sufficient repetition of tuberculosis-specific testing. The patient was treated with isoniazid-rifampin-pyrazinamide-ethambutol for 2 months, then isoniazid and rifampin for 7 months, with full recovery in follow-up.

conclusionsThis case highlights the importance of a clinical-based approach in the treatment of patients with psoas abscesses, especially in areas with high tuberculosis prevalence.

Indexed as

Psoas AbscessTuberculosisAdultAntitubercular AgentsFemaleHumansIsoniazidPyrazinamideRifampinAntitubercular AgentsIsoniazidPyrazinamideRifampinAbscessCase reportExtrapulmonary tuberculosisIlium wingPsoas

Identifiers

PMID35581665
PMCPMC9115972
OpenAlexW4280553075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.